Septerna (SEPN) Change in Cash (2023 - 2026)
Septerna (SEPN) recorded quarterly Change in Cash of -$49.1 million in Q1 2026, up 75.35% quarter-over-quarter from -$199.3 million in Q4 2025, and down 74.48% on a YoY basis from -$192.4 million in Q1 2025.
Septerna (SEPN) Change in Cash (2023 - 2026) Analysis & Trends
Septerna's Change in Cash history runs 4 years deep, the most recent figure standing at -$49.1 million for Q1 2026.
- In Q1 2026, Change in Cash fell 74.48% year-over-year to -$49.1 million; the TTM figure through Mar 2026 stood at -$138.4 million (down 207.56% YoY), while the FY2025 annual figure was -$117.5 million, down 178.47% from the prior year.
- Change in Cash was -$49.1 million for Q1 2026 at Septerna, up from -$199.3 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $150.0 million in Q4 2024 to a low of -$199.3 million in Q4 2025.
- Historically, Change in Cash has averaged -$2.7 million across 4 years, with a median of -$15.4 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Change in Cash surged 1594.16% in 2024, then sank 294.11% in 2025.
- A 4-year view of Change in Cash shows it stood at -$10.0 million in 2023, then soared by 1594.16% to $150.0 million in 2024, then tumbled by 232.89% to -$199.3 million in 2025, then surged by 75.35% to -$49.1 million in 2026.
- The last three Change in Cash figures came in at -$49.1 million (Q1 2026), -$199.3 million (Q4 2025), and $130.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -45.97 Mn |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - | -49.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.12 Mn |
| Dec 31, 2025 | -199.27 Mn |
| Sep 30, 2025 | 130.68 Mn |
| Jun 30, 2025 | -20.73 Mn |
| Mar 31, 2025 | -28.15 Mn |
| Dec 31, 2024 | 149.95 Mn |
| Sep 30, 2024 | -42.93 Mn |
| Jun 30, 2024 | 49.83 Mn |
| Mar 31, 2024 | -7.14 Mn |
| Dec 31, 2023 | -10.04 Mn |